Structures of lipoprotein signal peptidase II from Staphylococcus aureus complexed with antibiotics globomycin and myxovirescin.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Scanlan, Eoin M
Geoghegan, Joan A
MetadataShow full item record
AbstractAntimicrobial resistance is a major global threat that calls for new antibiotics. Globomycin and myxovirescin are two natural antibiotics that target the lipoprotein-processing enzyme, LspA, thereby compromising the integrity of the bacterial cell envelope. As part of a project aimed at understanding their mechanism of action and for drug development, we provide high-resolution crystal structures of the enzyme from the human pathogen methicillin-resistant Staphylococcus aureus (MRSA) complexed with globomycin and with myxovirescin. Our results reveal an instance of convergent evolution. The two antibiotics possess different molecular structures. Yet, they appear to inhibit identically as non-cleavable tetrahedral intermediate analogs. Remarkably, the two antibiotics superpose along nineteen contiguous atoms that interact similarly with LspA. This 19-atom motif recapitulates a part of the substrate lipoprotein in its proposed binding mode. Incorporating this motif into a scaffold with suitable pharmacokinetic properties should enable the development of effective antibiotics with built-in resistance hardiness.
CitationNat Commun. 2020 Jan 9;11(1):140. doi: 10.1038/s41467-019-13724-y.
AffiliationHIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.
PublisherNature publishing group
The following license files are associated with this item:
- Creative Commons
- Genetic redundancy, proximity, and functionality of lspA, the target of antibiotic TA, in the Myxococcus xanthus producer strain.
- Authors: Xiao Y, Wall D
- Issue date: 2014 Mar
- Unstable Mechanisms of Resistance to Inhibitors of Escherichia coli Lipoprotein Signal Peptidase.
- Authors: Pantua H, Skippington E, Braun MG, Noland CL, Diao J, Peng Y, Gloor SL, Yan D, Kang J, Katakam AK, Reeder J, Castanedo GM, Garland K, Komuves L, Sagolla M, Austin CD, Murray J, Xu Y, Modrusan Z, Xu M, Hanan EJ, Kapadia SB
- Issue date: 2020 Sep 8
- Structural basis of lipoprotein signal peptidase II action and inhibition by the antibiotic globomycin.
- Authors: Vogeley L, El Arnaout T, Bailey J, Stansfeld PJ, Boland C, Caffrey M
- Issue date: 2016 Feb 19
- Myxobacterium-produced antibiotic TA (myxovirescin) inhibits type II signal peptidase.
- Authors: Xiao Y, Gerth K, Müller R, Wall D
- Issue date: 2012 Apr
- LspA-independent action of globomycin on Mycobacterium tuberculosis.
- Authors: Banaiee N, Jacobs WR, Ernst JD
- Issue date: 2007 Aug